What is the maximum dose of noradrenaline (norepinephrine) per kilogram per minute?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Dose of Noradrenaline (Norepinephrine)

The maximum dose of noradrenaline (norepinephrine) is 5 mcg/kg/min for pediatric patients, though typical dosing ranges from 0.1-1.0 mcg/kg/min. 1

Dosing Guidelines

Pediatric Patients

  • Initial dosing should start at the lowest effective dose (0.1 mcg/kg/min) and titrate to desired clinical effect 1
  • Typical maintenance dosing ranges from 0.1-1.0 mcg/kg/min 1
  • Doses as high as 5 mcg/kg/min are sometimes necessary in children with refractory shock 1, 2
  • A retrospective study of children with septic shock reported mean maximum doses of 2.5 ± 2.2 μg/kg/min, indicating that higher doses than typically recommended may be necessary in severe cases 2

Adult Patients

  • Initial dose typically ranges from 8-12 mcg of base per minute (0.25-0.375 mL/min of standard concentration) 3
  • Average maintenance dose ranges from 2-4 mcg of base per minute (0.0625-0.125 mL/min) 3
  • Doses should be adjusted to establish and maintain a blood pressure sufficient to maintain vital organ perfusion (usually 80-100 mmHg systolic) 3

Severity Classification Based on Dose

Recent research has proposed classifying norepinephrine dosing into severity categories 4:

  • Low dose: <0.2 μg/kg/min
  • Intermediate dose: 0.2-0.4 μg/kg/min
  • High dose: >0.4 μg/kg/min

These categories correlate with increasing hospital mortality rates, with high doses (>0.4 μg/kg/min) associated with significantly higher mortality 4.

Administration Considerations

Route of Administration

  • Central venous access is preferred for administration of norepinephrine 1
  • If central access is unavailable, peripheral IV or intraosseous routes can be used temporarily 1
  • For pediatric patients, peripheral venous access or intraosseous routes have been used safely for short durations (median 3 hours) without adverse effects 2

Monitoring and Titration

  • Monitor blood pressure and heart rate every 5-15 minutes during initial titration 1
  • Titrate to achieve target mean arterial pressure or adequate tissue perfusion 1
  • For septic shock, target normalization of capillary refill and age-appropriate heart rate 1

Complications and Precautions

  • Extravasation can result in severe skin injury; phentolamine (0.1-0.2 mg/kg up to 10 mg diluted in 10 mL of 0.9% sodium chloride) injected intradermally at the extravasation site may counteract dermal vasoconstriction 5
  • High-dose norepinephrine therapy may be futile in patients with severe metabolic acidemia (bicarbonate levels <9.0 mEq/L) 6
  • Potential side effects include ischemic injury, bradycardia, anxiety, transient headache, respiratory difficulty, and arrhythmias 3
  • Ensure adequate volume resuscitation before and during norepinephrine administration to optimize cardiac output 1

Special Considerations

  • For obese patients, weight-based dosing may result in overdosing; studies show obese patients require lower weight-based doses compared to non-obese patients (0.09 vs 0.13 μg/kg/min) 7
  • Norepinephrine has been shown to be superior to dopamine in patients with cardiogenic shock, with fewer arrhythmic events 8
  • The cause of shock and treatment with high-dose norepinephrine are not predictive of death, but severe disease and metabolic acidemia are associated with poor outcomes 6

References

Guideline

Norepinephrine Drip Administration Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

High-dose norepinephrine treatment: determinants of mortality and futility in critically ill patients.

American journal of critical care : an official publication, American Association of Critical-Care Nurses, 2013

Research

Norepinephrine Dosing in Obese and Nonobese Patients With Septic Shock.

American journal of critical care : an official publication, American Association of Critical-Care Nurses, 2016

Research

Comparison of dopamine and norepinephrine in the treatment of shock.

The New England journal of medicine, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.